MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
HCW Biologics Inc. (NASDAQ: HCWB)*
Organization & Developments: HCW
Parents
HCW Biologics Inc. (NASDAQ: HCWB)*
Children
*Company’s immunotherapeutics represent a new class of drug that it believes have the potential to fundamentally change the treatment of cancer and many other diseases and conditions that are promoted by chronic inflammation — and in doing so, improve patients’ quality of life and potentially extend longevity.
*Lead drug candidate is HCW9302 and immunotherapeutic compounds comprised of a single-chain chimeric polypeptide with two target-binding domains on a scaffold made of an extracellular domain of human tissue factor.
2025: HCW Biologics T-Cell Therapy Achieves 100% Survival Rate in Pancreatic Cancer Trial
Jumps
Finance & Acquisitions: HCW
Key People: HCW